Neoplastic Conditions in the Context of HIV-1 Infection
Journal:
Current HIV Research
Volume:
2
Page:
343-349
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan
Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate
Journal:
Letters in Drug Design & Discovery
Volume:
1
Page:
247-255
Author(s):
P. S. Cogan, C. R. Fowler, G. C. Post and T. H. Koch
Immunotoxins and Other Conjugates: Pre-clinical Studies
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
563-583
Author(s):
A. Bolognesi and L. Polito
Drug Delivery Systems for Brain Tumor Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1341-1353
Author(s):
Jarkko Rautioa and Prashant J. Chikhale
Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1161-1181
Author(s):
Brian T. Hoffman, Melanie R. Nelson, Keith Burdick and Susan M. Baxter
AT Islands - Their Nature and Potential for Anticancer Strategies
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
219-234
Author(s):
Jan M. Woynarowski
Multidrug Resistance in Cancer Chemotherapy and Xenobiotic Protection Mediated by the Half ATP-Binding Cassette Transporter ABCG2
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
31-42
Author(s):
B. Han and J.- T. Zhang
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Journal:
Current Drug Targets
Volume:
4
Page:
525-536
Author(s):
Dmitry Gabrilovich and Vladimir Pisarev
CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus
Journal:
Current Molecular Medicine
Volume:
3
Page:
341-347
Author(s):
Casper Paludan and Christian Munz